Form 144 | Dyne Therapeutics(DYN.US) Insider Proposes to Sell 49.25 Million in Common Stocks

SEC FILLINGS DISCLOSED/ Nov 14, $Dyne Therapeutics(DYN.US)$ Insider ForDyne B.V. intends to sell 1.5 million shares of its common stock on Nov 14, with a total market value of approximately $49.25

Moomoo NewsNov 14 17:02 ET

Dyne Therapeutics Reveals Q3 Results and Trial Updates

TipRanksNov 13 22:58 ET

Dyne Therapeutics Is Maintained at Buy by Chardan Capital

Dow JonesNov 13 18:43 ET · Ratings

Oppenheimer Maintains Dyne Therapeutics(DYN.US) With Buy Rating, Maintains Target Price $55

Moomoo NewsNov 13 08:31 ET · Ratings

Oppenheimer Sticks to Their Buy Rating for Dyne Therapeutics (DYN)

TipRanksNov 13 08:08 ET · Ratings

Express News | Dyne Therapeutics Inc : Raymond James Cuts Target Price to $49 From $56

ReutersNov 13 07:38 ET